Moderna mRNA 1273 P403-M (SARS Cov 2) Vaccine Trial Neutralizing Antibody Assessment and SARS-CoV-2 Variant Characterization and Validation
Research Grant
Administered By
Surgery, Surgical Sciences
Awarded By
Moderna Therapeutics, Inc.
Start Date
October 3, 2024
End Date
October 2, 2026
Administered By
Surgery, Surgical Sciences
Awarded By
Moderna Therapeutics, Inc.
Start Date
October 3, 2024
End Date
October 2, 2026